» Home » Drug Database » Androstanes » abiraterone
ADVERTISEMENT
ADVERTISEMENT
» Home » Drug Database » Androstanes » abiraterone
Brand Name :
Synonyms :
Class :
No drug interaction found for abiraterone and .
may enhance the QTc-prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may diminish the serum concentration of CYP3A4 inducers
may diminish the serum concentration of CYP3A4 inducers
may diminish the serum concentration of CYP3A4 inducers
may diminish the serum concentration of CYP3A4 inducers
may diminish the serum concentration of CYP3A4 inducers
may diminish the serum concentration when combined with abiraterone acetate
may diminish the serum concentration when combined with abiraterone acetate
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
CYP3A4 Inhibitors: they may diminish the serum concentration of hormonal contraceptives
CYP3A4 Inhibitors: they may diminish the serum concentration of hormonal contraceptives
CYP3A4 Inhibitors: they may diminish the serum concentration of hormonal contraceptives
CYP3A4 Inhibitors: they may diminish the serum concentration of hormonal contraceptives
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
may decrease the serum concentration of Quinolones
may increase the serum concentration of colchicine
may increase the levels of serum concentration of ivacaftor/tezacaftor
may enhance the serum concentration
may enhance the serum concentrations of active metabolites
may reduce the therapeutic effect of gallium
may enhance the serum concentration
may increase the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration when combined with nifedipine
may enhance serum concentrations when combined with tetrabenazine
may increase the serum concentration of abemaciclib
may increase the level of serum concentration of adagrasib
may increase the level of serum concentration of adagrasib
may increase or decrease the activity of this enzyme when combined with sparsentan
May enhance the serum concentration when combined with levomilnacipran
may enhance the serum concentration when combined with upadacitinib
may enhance the serum concentration when combined with fenfluramine
may enhance the serum concentration when combined with fenfluramine
may diminish the serum concentration when combined with CYP2D6 substrates
may decrease the therapeutic effect of each other when combined
may enhance the serum concentration
may increase the QTc prolonging effect of QT-prolonging Class III Antiarrhythmics
may decrease the therapeutic effect when combined with lenograstim
may diminish the therapeutic effect when combined with lipegfilgrastim
may increase the adverse effect when combined with antineoplastic agents
may increase the serum concentration of Rasagiline
may diminish the serum concentration of CYP3A4 Inducers
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may enhance the concentration when combined with serum of selexipag
may enhance the concentration of serum when combined with theophylline derivatives
may diminish the serum concentration of Voxelotor
may enhance the concentration of serum when combined with thioridazine
may enhance the concentration of serum when combined with treprostinil
may decrease the diagnostic effect when combined with Piflufolastat F18
lonafarnib: they may enhance the serum concentration of CYP3A4 Inhibitors
pirfenidone: they may enhance the serum concentration of CYP1A2 Inhibitors
pomalidomide: they may enhance the serum concentration of CYP1A2 Inhibitors
propranolol: they may enhance the serum concentration of CYP1A2 Inhibitors
sirolimus: they may enhance the serum concentration of CYP3A4 Inhibitors
budesonide: they may enhance the serum concentration of CYP3A4 Inhibitors
may diminish the metabolism of each other when combined
ripretinib: they may diminish the serum concentration of CYP3A4 Inducers
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
alfentanil: they may enhance the serum concentration of CYP3A Inhibitors
avanafil: they may enhance the serum concentration of CYP3A Inhibitors
budesonide: they may enhance the serum concentration of CYP3A Inhibitors
bromocriptine: they may enhance the serum concentration of CYP3A Inhibitors
cilostazol: they may enhance the serum concentration of CYP3A Inhibitors
cisapride: they may enhance the serum concentration of CYP3A Inhibitors
dapoxetine: they may enhance the serum concentration of CYP3A Inhibitors
daridorexant: they may enhance the serum concentration of CYP3A Inhibitors
eliglustat: they may enhance the serum concentration of CYP3A Inhibitors
encorafenib: they may enhance the serum concentration of CYP3A Inhibitors
eplerenone: they may enhance the serum concentration of CYP3A Inhibitors
fentanyl: they may enhance the serum concentration of CYP3A Inhibitors
ivacaftor: they may enhance the serum concentration of CYP3A Inhibitors
lumateperone: they may enhance the serum concentration of CYP3A Inhibitors
mitapivat: they may enhance the serum concentration of CYP3A Inhibitors
naloxegol: they may enhance the serum concentration of CYP3A Inhibitors
may increase the levels of serum concentration of ergot derivatives
may increase the levels of serum concentration of ergot derivatives
may increase the levels of serum concentration of ergot derivatives
may increase the levels of serum concentration of ergot derivatives
may increase the levels of serum concentration of ergot derivatives
may increase the levels of serum concentration of ergot derivatives
CYP2D6 inhibitors increase the concentration of aripiprazole in the serum
they decrease the concentration of active metabolites of roflumilast in the serum
may increases the level of effectiveness through P-glycoprotein MDR1 efflux transporter
it increases the concentration of CYP3A4 substrates in the serum
it increases the concentration of CYP3A4 substrates in serum
may increase the levels of serum concentration of eletriptan
they increase the concentration of alosetron in the serum
may enhance the serum concentration
may enhance the serum concentration
they decrease the concentration of active metabolites of infigratinib in the serum
CYP3A4 inhibitors increase the concentration of pimozide in the serum
may increase the serum concentration of acalabrutinib
they decrease the concentration of active metabolites of iloperidone in the serum
CYP3A4 inhibitors increase the concentration of active metabolites of simvastatin in the serum
may enhance the serum concentration of simeprevir
may enhance the serum concentration
may enhance the serum concentration of fostemsavir
may enhance the serum concentrations of flibanserin
may enhance the serum concentration of tafamidis
may enhance the serum concentration when combined
they decrease the concentration of lurbinectedin in the serum
antiandrogens decrease the efficacy of choline C11
may diminish the concentration of serum when combined with CYP1A2 substrates
may enhance the concentration of serum when combined with CYP2C8 substrates
may decrease the therapeutic effect when combined
agomelatine: they may enhance the serum concentration of CYP1A2 Inhibitors
duloxetine: they may enhance the serum concentration of CYP1A2 Inhibitors
melatonin: they may enhance the serum concentration of CYP1A2 Inhibitors
mexiletine: they may enhance the serum concentration of CYP1A2 Inhibitors
ramelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
tasimelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
may enhance the concentration of serum when combined with mavacamten
indium In-111 capromab pendetide
may decrease the diagnostic effect when combined
indium In-111 capromab pendetide
may decrease the diagnostic effect when combined
may increase the serum concentration of each other when combined
may altering the drug metabolism when combined with kratom
fexinidazole: they may enhance the serum concentration of CYP3A4 inhibitors
fusidic acid: they may enhance the serum concentration of CYP3A inhibitors
trabectedin: they may diminish the serum concentration of CYP3A Inhibitors
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
bazedoxifene/conjugated estrogens
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
synthetic conjugated estrogens, a
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
synthetic conjugated estrogens, b
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
may increase the serum concentration of ergot derivatives
may increase the serum concentration of ergot derivatives
may increase the serum concentration of ergot derivatives
may increase the serum concentration of ergot derivatives
may increase the serum concentration of ergot derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
bazedoxifene/conjugated estrogens
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
bazedoxifene/conjugated estrogens
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
May decrease the serum concentration
May decrease the serum concentration
May decrease the serum concentration
May decrease the serum concentration
May decrease the serum concentration
synthetic conjugated estrogens, a
may increase the serum concentration
synthetic conjugated estrogens, b
may increase the serum concentration
may increase the serum concentration
may increase the QTc-prolonging effect
may increase the QTc-prolonging effect
may increase the QTc-prolonging effect
may increase the QTc-prolonging effect
it may diminish the metabolism when combined with zuclopenthixol
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentrations
may increase the levels of serum concentrations
may increase the levels of serum concentrations
may increase the levels of serum concentrations
may increase the levels of serum concentrations
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
acetaminophen and phenyltoloxamine
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
acetaminophen and phenyltoloxamine
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
It may enhance the effect when combined with cannabidiol by affecting CYP3A4 metabolism
may increase the levels of serum concentration
when netupitant is combined with abiraterone, it can lead to a reduced metabolism of abiraterone
When antipyrine is combined with abiraterone, its concentration serum may also elevated
antiviral agents (HCV): they may increase the hypoglycemic effect of antidiabetic drugs
It may enhance the levels when combined with tamsulosin by affecting CYP2D6 metabolism
The combination of troleandomycin may lead to a reduced metabolism of abiraterone
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
Combining levobetaxolol and abiraterone can diminish levobetaxolol’s metabolism
Combining tegafur with abiraterone can reduce tegafur’s metabolism
may enhance the serum concentration
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration
it increases the concentration of CYP3A4 substrates in the serum
they decrease the concentration of active metabolites of roflumilast in the serum
may increase the levels of serum concentrations of clobazam
may increase the serum concentration
hydrocodone/chlorpheniramine/pseudoephedrine
may diminish the serum concentration
it increases the concentration of alosetron in the serum
they decrease the concentration of linagliptin in the serum
may enhance the serum concentration
may increase the serum concentration of clozapine
may increase the levels of serum concentrations of cariprazine
may enhance the serum concentration
may increase the serum concentration
may increase the serum concentration of CYP3A4 substrates
may increase the serum concentration of erdafitinib
azelastine/fluticasone intranasal
may enhance the serum concentration
may enhance the serum concentration of macitentan
may decrease the serum concentration of CYP2C9 substrates
may increase the serum concentration of abemaciclib
may increase the serum concentration of zopiclone
may increase the serum concentration
may enhance the serum concentration of CYP3A4 inhibitor
may enhance the serum concentration of CYP2C19 Inhibitors
may increase the toxic effect of opioid agonists
may increase the serum concentration
may increase the serum concentration of amphetamines
may enhance the serum concentration
may enhance the serum concentration when combined with CYP2D6 substrates
may diminish serum concentrations when combined with doxercalciferol
may enhance the serum concentrations
may enhance the serum concentrations of CYP2D6 inhibitors
may increase the level of serum concentration of itraconazole
may increase the level of serum concentration of itraconazole
CYP3A4 inhibitors increase the concentration of carbamazepine in the serum
CYP3A4 inhibitors increase the concentration of iloperidone in the serum
CYP3A4 inhibitors increase the concentration of finerenone in the serum
CYP3A4 inhibitors increase the concentration of tacrolimus in the serum
may increase the serum concentration of pimecrolimus
may increase the serum concentration
may enhance the serum concentration of flibanserin
may increase the serum concentration of active metabolites
CYP3A4 inhibitors increase the concentration of rivaroxaban
may reduce the effect of zavegepant
may increase the hypertensive effect of hypertension-associated agents
may diminish the serum concentration of Sulfonylureas
may increase the hypoglycemic effect of Antidiabetic Agents
may diminish the serum concentration of Lidocaine
may increase the serum concentration of Lidocaine
may increase the serum concentration of Dextromethorphan
may increase the levels of serum concentration of pimavanserin
may increase the levels of serum concentration
it enhance the risk of pulmonary toxicity
may increase the myopathic effect of HMG-CoA Reductase Inhibitors
may diminish the serum concentration when combined with CYP2C8 substrates
may enhance the concentration of serum when combined with timolol
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
bazedoxifene/conjugated estrogens
may increase the levels of serum concentration
synthetic conjugated estrogens, a
may increase the levels of serum concentration
synthetic conjugated estrogens, b
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
estrogens esterified/methyltestosterone
may increase the thrombogenic effect of androgens
clozapine: they may enhance the serum concentration of CYP1A2 Inhibitors
It may enhance the serum concentration when combined with CYP3A4 Inhibitors
It may enhance the serum concentration when combined with CYP2C19 Inhibitors
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
may enhance the concentration of serum when combined with asenapine
acetaminophen/doxylamine/dextromethorphan
may enhance the serum concentration when combined
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
rifabutin: they may diminish the serum concentration of abiraterone
may increase the hypoglycemic effect of Antidiabetic Agents
may increase the Glucose-lowering effect of Antidiabetic Agents
may enhance the concentration of serum when combined with treprostinil
may enhance the serum concentration of Vitamin D Analogs
may increase the levels of serum concentration
it may enhance the serum concentration when combined with azelastine
they decrease the efficacy of choline C11
anagrelide: they may enhance serum concentrations of CYP1A2 Inhibitors
bromazepam: they may enhance the serum concentration of CYP1A2 Inhibitors
clomipramine: they may enhance the serum concentration of CYP1A2 Inhibitors
flibanserin: they may enhance the serum concentration of CYP3A Inhibitors
dofetilide: they may enhance the serum concentration of CYP3A Inhibitors
finerenone: they may enhance the serum concentration of CYP3A Inhibitors
ixabepilone: they may enhance the serum concentration of CYP3A Inhibitors
levobupivacaine: they may enhance the serum concentration of CYP1A2 Inhibitors
lidocaine: they may enhance the serum concentration of CYP1A2 Inhibitors
nimodipine: they may enhance the serum concentration of CYP3A Inhibitors
olanzapine: they may enhance the serum concentration of CYP1A2 Inhibitors
pentoxifylline: they may enhance the serum concentration of CYP1A2 Inhibitors
ramosetron: they may enhance the serum concentration of CYP1A2 Inhibitors
riluzole: they may enhance the serum concentration of CYP1A2 Inhibitors
simvastatin: they may enhance serum concentrations of CYP3A Inhibitors
ropinirole: they may enhance the serum concentration of CYP1A2 Inhibitors
ropivacaine: they may enhance the serum concentration of CYP1A2 Inhibitors
fusidic acid and betamethasone
may enhance the serum concentration when combined
may enhance the concentration of serum when combined with belzutifan
may enhance the concentration of serum when combined with brivaracetam
may diminish the concentration of serum when combined with clopidogrel
may enhance the concentration of serum when combined with dexlansoprazole
may enhance the concentration of serum when combined with lansoprazole
daprodustat: they may enhance the serum concentration of CYP2C8 Inhibitors
CYP2C8 Inhibitors: they may enhance the serum concentration of repaglinide
CYP2D6 Inhibitors: they may enhance the serum concentration of nebivolol
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
clofazimine: they may enhance the serum concentration of CYP3A inhibitors
mometasone (Nasal): they may enhance the serum concentration of CYP3A Inhibitors
may decrease the serum concentration when combined with CYP1A2 substrates
may decrease the serum concentration when combined with CYP1A2 substrates
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of glasdegib in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
they increase the concentration of active metabolites of CYP3A4 inhibitors in the serum
CYP3A4 inhibitors increase the concentration of ubrogepant in the serum
CYP3A4 inhibitors increase the concentration of sirolimus in the serum
CYP3A4 inducers increase the concentration of buspirone in the serum
they increase the concentration of metoclopramide in the serum
Androgen Deprivation Therapy Agents decrease the effect of diagnosis of flotufolastat F18
they decrease the concentration of active metabolites of tamoxifen in serum
ADVERTISEMENT
» Home » Drug Database » Androstanes » abiraterone
Brand Name :
Synonyms :
Class :
